- Home
- APD vs GSK Comparison
APD vs GSK Comparison
Compare APD & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APD | GSK |
|---|---|---|
| Founded | 1940 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7B | 98.9B |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | APD | GSK |
|---|---|---|
| Price | $249.85 | $49.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $282.45 | N/A |
| AVG Volume (30 Days) | 2.0M | ★ 3.0M |
| Earning Date | 02-05-2026 | 02-04-2026 |
| Dividend Yield | 2.86% | ★ 3.34% |
| EPS Growth | N/A | ★ 118.57 |
| EPS | N/A | ★ 1.79 |
| Revenue | $12,037,300,000.00 | ★ $43,237,357,842.00 |
| Revenue This Year | $4.87 | $6.70 |
| Revenue Next Year | $6.12 | $5.10 |
| P/E Ratio | ★ N/A | $13.42 |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $229.11 | $31.72 |
| 52 Week High | $341.14 | $49.63 |
Technical Indicators
Market Signals| Indicator | APD | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 52.43 | 62.04 |
| Support Level | $238.60 | $48.93 |
| Resistance Level | $245.71 | $49.40 |
| Average True Range (ATR) | 4.62 | 0.48 |
| MACD | 1.07 | -0.03 |
| Stochastic Oscillator | 91.71 | 95.41 |
Price Performance
Historical ComparisonAbout APD Air Products and Chemicals Inc.
Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $12.1 billion in revenue in fiscal 2024.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.